Yizhuo Zhang, MD, PhD, Sun Yat-Sen University Cancer Center, Guangzhou, China, discusses her highlights from the 2025 Chinese Anti-Cancer Association (CACA) Science & Technology Award Talks, including targeted immunotherapies for tumors such as neuroblastomas in pediatric patients. Prof. Zhang additionally highlights the importance of multidisciplinary teams and non-profits in pediatric oncology. This interview took place at the 2025 CACA Science & Technology Award Talks in Kunming, China.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.